IMIPENEM ANHYDROUS
Substance profile for UNII Q20IM7HE75, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Structure render from PubChem CID 104838Substance Identity#
- UNII
- Q20IM7HE75
- Preferred term
- IMIPENEM ANHYDROUS
- Registry number
- 64221-86-9
- EC number
- 264-734-5
- Ingredient type
- INGREDIENT SUBSTANCE
- Molecular formula
- C12H17N3O4S
Structure render from PubChem CID 104838Chemical And Database Identifiers#
- InChIKey
- ZSKVGTPCRGIANV-ZXFLCMHBSA-N
- SMILES
- C[C@@H](O)[C@@H]1[C@H]2CC(SCCNC=N)=C(N2C1=O)C(O)=O
- RxCUI
- 1545986
- PubChem
- 104838
- NCIt
- C146984
- INN ID
- 5181
DailyMed Socrata Ingredients#
DailyMed label, SPL version table| DailyMed label | SPL version |
|---|
| IMIPENEM AND CILASTATIN INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.] | 25 |
| IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.] | 23 |
| PRIMAXIN IV (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION [MERCK SHARP & DOHME CORP.] | 16 |
| IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 4 |
| IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.] | 4 |
| PRIMAXIN IV (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION [CARDINAL HEALTH] | 3 |
| IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION [CARDINAL HEALTH] | 2 |
| IMIPENEM AND CILASTATIN (IMIPENEM AND CILASTATIN SODIUM) INJECTION, POWDER, FOR SOLUTION [FRESENIUS KABI USA, LLC] | 2 |
| PRIMAXIN IV (IMIPENEM) INJECTION, POWDER, FOR SOLUTION [MERCK SHARP & DOHME CORP.] | 1 |